AMSub 19 Parti F S990-S991 AWS
. . . PARTICIPATING FACULTY . . . New Dimensions in Cholesterol Control Proceedings in this Special Report supplement to The American Journal of Managed Care are based on presentations and roundtable discussions that took place during an educational symposium held in San Francisco, California, on July 15, 2000. This supplement has been peer reviewed by an expert in the field.
SYMPOSIUM FACULTY Chairs James M. McKenney, PharmD President National Clinical Research Richmond, Virginia
Donald B. Hunninghake, MD Professor of Medicine University of Minnesota Heart Disease Prevention Clinic Minneapolis, Minnesota
Panel Antonio M. Gotto, Jr, MD, DPhil Professor of Medicine Cornell University Medical College Office of the Dean Weill Medical College of Columbia University New York, New York
Jawahar L. Mehta, MD, PhD Stebbins Professor of Internal Medicine and Physiology Chief, Division of Cardiovascular Disease University of Arkansas for Medical Sciences Little Rock, Arkansas
Peter H. Jones, MD Associate Professor of Medicine Department of Medicine Section of Atherosclerosis and Lipoprotein Research Baylor College of Medicine Houston, Texas
S990
THE AMERICAN JOURNAL OF MANAGED CARE
NOVEMBER 2000
DISCLOSURE STATEMENT It is the policy of The American Journal of Managed Care to have all faculty who participate in programs sponsored by corporate organizations disclose any real or apparent conflicts of interest. These participants have declared the following affiliations with corporate organizations. ■
Antonio M. Gotto, Jr, MD, DPhil Consultant For: Merck Bristol-Myers Squibb Pfizer Novartis AstraZeneca
■
Donald B. Hunninghake, MD Grant/Research Support From: Pfizer/Parke-Davis KOS Sankyo Novartis Wyeth-Ayerst Merck Bristol-Myers Squibb Bayer AstraZeneca Consultant For: Pfizer/Parke-Davis AstraZeneca KOS Sankyo
■
Peter H. Jones, MD Research Grant Support From: Bayer Pfizer KOS TAP
■
James M. McKenney, PharmD Research Support From: Bristol-Myers Squibb Merck Pfizer Aura KOS Schering-Plough GlaxoWellcome Searle AstraZeneca Bayer Consultant For: Bristol-Myers Squibb Pfizer Aura GlaxoWellcome Novartis
■
Jawahar L. Mehta, MD, PhD Grant/Lecture Support From: Bristol-Myers Squibb Sankyo Parke-Davis Pfizer Merck
Signed disclosures are on file at the offices of The American Journal of Managed Care, Jamesburg, New Jersey.
VOL. 6, NO. 19, SUP.
THE AMERICAN JOURNAL OF MANAGED CARE
S991
New Dimensions in Cholesterol Control
This program is supported by an unrestricted educational grant from Sankyo Pharma Inc.
The content of this Special Report supplement may include information regarding the use of products that may be inconsistent with or outside the approved labeling for these products in the United States. Physicians should note that the use of these products outside current approved labeling is considered experimental and are advised to consult prescribing information for these products.
THE AMERICAN JOURNAL OF MANAGED CARE
SYMPOSIUM FACULTY Chairs James M. McKenney, PharmD President National Clinical Research Richmond, Virginia
Donald B. Hunninghake, MD Professor of Medicine University of Minnesota Heart Disease Prevention Clinic Minneapolis, Minnesota
Panel Antonio M. Gotto, Jr, MD, DPhil Professor of Medicine Cornell University Medical College Office of the Dean Weill Medical College of Columbia University New York, New York
Jawahar L. Mehta, MD, PhD Stebbins Professor of Internal Medicine and Physiology Chief, Division of Cardiovascular Disease University of Arkansas for Medical Sciences Little Rock, Arkansas
Peter H. Jones, MD Associate Professor of Medicine Department of Medicine Section of Atherosclerosis and Lipoprotein Research Baylor College of Medicine Houston, Texas
S990
THE AMERICAN JOURNAL OF MANAGED CARE
NOVEMBER 2000
DISCLOSURE STATEMENT It is the policy of The American Journal of Managed Care to have all faculty who participate in programs sponsored by corporate organizations disclose any real or apparent conflicts of interest. These participants have declared the following affiliations with corporate organizations. ■
Antonio M. Gotto, Jr, MD, DPhil Consultant For: Merck Bristol-Myers Squibb Pfizer Novartis AstraZeneca
■
Donald B. Hunninghake, MD Grant/Research Support From: Pfizer/Parke-Davis KOS Sankyo Novartis Wyeth-Ayerst Merck Bristol-Myers Squibb Bayer AstraZeneca Consultant For: Pfizer/Parke-Davis AstraZeneca KOS Sankyo
■
Peter H. Jones, MD Research Grant Support From: Bayer Pfizer KOS TAP
■
James M. McKenney, PharmD Research Support From: Bristol-Myers Squibb Merck Pfizer Aura KOS Schering-Plough GlaxoWellcome Searle AstraZeneca Bayer Consultant For: Bristol-Myers Squibb Pfizer Aura GlaxoWellcome Novartis
■
Jawahar L. Mehta, MD, PhD Grant/Lecture Support From: Bristol-Myers Squibb Sankyo Parke-Davis Pfizer Merck
Signed disclosures are on file at the offices of The American Journal of Managed Care, Jamesburg, New Jersey.
VOL. 6, NO. 19, SUP.
THE AMERICAN JOURNAL OF MANAGED CARE
S991
New Dimensions in Cholesterol Control
This program is supported by an unrestricted educational grant from Sankyo Pharma Inc.
The content of this Special Report supplement may include information regarding the use of products that may be inconsistent with or outside the approved labeling for these products in the United States. Physicians should note that the use of these products outside current approved labeling is considered experimental and are advised to consult prescribing information for these products.
THE AMERICAN JOURNAL OF MANAGED CARE
